Mile High Labs recently opened its new 400,000-square-foot facility in Broomfield, CO. The large-scale CBD ingredient and product manufacturer purchased and closed on the facility on June 19, and the transaction included the land, labs, building, and ready-to-use finished products manufacturing equipment. The space was previously a pharmaceutical facility. The company produces private label products including tinctures, capsules, tablets, topicals, and gummies, and the facility includes equipment and infrastructure for research and development, quality assurance, bottling, filling, packing, warehousing, labeling, shipping, and compliance monitoring. “In light of recent legislative developments, the demand for our products has increased considerably,” says Stephen Mueller, chief technology officer and founder of Mile High Labs. “And it’s not just a domestic phenomenon. CBD is a global product and we serve a global customer base. This large-scale production facility will ensure we have the capacity to provide high quality, consistent CBD to every customer, large or small.”
RELATED STORIES
Purdue Receives USDA Grant To Study Organic Hemp Production
QAI Offers USDA Organic Certification For Hemp Crops And Products
Arthritis Foundation Releases First CBD Guidelines for Adults with Arthritis